spacer
home > pmps > winter 2003 > new developments in the containment of pharmaceutical powders
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Developments in the Containment of Pharmaceutical Powders

There is a growing trend for routine day-to-day pharmaceutical powder processing and production operations to involve 'high potency' powders. To meet this challenge new strategies for powder handling are being developed along with engineering advances in the equipment used to contain the active or high potency materials. The term 'containment', of course, refers to the isolation of hazardous materials (high potency) using engineering methods in various guises. Containment can protect the operator from the compound or protect the compound from operator-borne containment. In some cases specialised containment devices protect the operator from the materials and vice versa.

First of all it is important to appreciate the growth of high potency compounds within the pharmaceutical industry. In 1990, only about five per cent of all pharmaceutical actives handled were considered potent. Now in the year 2001, over 30 per cent of all APIs are classified as 'potent', and therefore require special attention to protect the operator from the effects of coming into contact with these materials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Martyn Ryder, Director of Extract Technology, part of the Carlisle Sciences Group

Martyn Ryder, Vice President of Business Development at Carlisle Life Sciences Europe, was educated at Leeds Polytechnic in HVAC and Building Services. In 1981 he founded Extract Technology, a company which has grown to be one of the world's leading suppliers of pharmaceutical dust control and high containment systems. The company is now part of the Carlisle Life Sciences Group, a division of Carlisle Corporation, a diversified global manufacturing company, serving the transportation, construction, commercial roofing, automotive, food service, data transmission and pharmaceutical and biotech industries.

spacer
Martyn Ryder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement